标题
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
作者
关键词
Clinical trials, disease modification, neuroprotection, Parkinson disease, pathogenesis
出版物
Neurotherapeutics
Volume 11, Issue 1, Pages 6-23
出版商
Springer Nature
发表日期
2013-10-01
DOI
10.1007/s13311-013-0218-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Application of Stem Cell Technology toward the Treatment of Parkinson^|^#8217;s Disease
- (2013) Kaneyasu Nishimura et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- The prion hypothesis in Parkinson's disease: Braak to the future
- (2013) Naomi P Visanji et al. Acta Neuropathologica Communications
- Use of Calcium Channel Blockers and Parkinson’s Disease
- (2012) Björn Pasternak et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- α-Synuclein oligomers and clinical implications for Parkinson disease
- (2012) Lorraine V. Kalia et al. ANNALS OF NEUROLOGY
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- Zonisamide Attenuates MPP(+)-Induced Oxidative Toxicity Through Modulation of Ca2+ Signaling and Caspase-3 Activity in Neuronal PC12 Cells
- (2012) Vedat Ali Yürekli et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
- (2012) S. K. Kalia et al. CNS & Neurological Disorders-Drug Targets
- Clinical experience with stem cells and other cell therapies in neurological diseases
- (2012) Dimitrios Karussis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
- (2012) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Biomarkers for trials of neuroprotection in Parkinson's disease
- (2012) Pankaj A. Agarwal et al. MOVEMENT DISORDERS
- Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
- (2012) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Design innovations and baseline findings in a long-term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long-Term Study-1
- (2012) Jordan J. Elm et al. MOVEMENT DISORDERS
- Trial designs used to study neuroprotective therapy in Parkinson's disease
- (2012) Anthony E. Lang et al. MOVEMENT DISORDERS
- Caffeine and risk of Parkinson's disease in a large cohort of men and women
- (2012) Natalia Palacios et al. MOVEMENT DISORDERS
- Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies
- (2012) Erwan Bezard et al. MOVEMENT DISORDERS
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?
- (2012) Anna R. Carta et al. NEUROTOXICITY RESEARCH
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- Dihydropyridine calcium channel blockers and the progression of parkinsonism
- (2011) Connie Marras et al. ANNALS OF NEUROLOGY
- Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity
- (2011) Mohammed Emamussalehin Choudhury et al. BRAIN RESEARCH
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial
- (2011) Robert E Gross et al. LANCET NEUROLOGY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
- (2011) Peter Jenner et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- An introduction to adaptive designs and adaptation in CNS trials
- (2010) Vladimir Dragalin EUROPEAN NEUROPSYCHOPHARMACOLOGY
- GM1 ganglioside in Parkinson's disease: Results of a five year open study
- (2010) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Post-MPTP Treatment with Granulocyte Colony-Stimulating Factor Improves Nigrostriatal Function in the Mouse Model of Parkinson’s Disease
- (2010) Mark McCollum et al. MOLECULAR NEUROBIOLOGY
- Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study
- (2010) Tanya Simuni et al. MOVEMENT DISORDERS
- Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
- (2010) Michael S. Okun et al. MOVEMENT DISORDERS
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease
- (2010) C. Savio Chan et al. MOVEMENT DISORDERS
- Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future
- (2010) Anthony E Lang NATURE MEDICINE
- Genetic Animal Models of Parkinson's Disease
- (2010) Ted M. Dawson et al. NEURON
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
- (2010) Kenneth A. Follett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating interleukin-10 and interleukin-12 in Parkinson’s disease
- (2009) M. Rentzos et al. ACTA NEUROLOGICA SCANDINAVICA
- Modeling Parkinson's disease
- (2009) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Dopaminergic transplantation for parkinson's disease: Current status and future prospects
- (2009) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
- (2009) Orit Bar-Am et al. JOURNAL OF NEUROCHEMISTRY
- Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease
- (2009) Robert A. Hauser et al. MOVEMENT DISORDERS
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease
- (2009) Ofer Sadan et al. STEM CELLS AND DEVELOPMENT
- Diet, Urate, and Parkinson's Disease Risk in Men
- (2008) X. Gao et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
- (2008) Michael A. Schwarzschild ARCHIVES OF NEUROLOGY
- Targets for neuroprotection in Parkinson's disease
- (2008) Talene A. Yacoubian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease
- (2008) Hyun Jung Park et al. JOURNAL OF NEUROCHEMISTRY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
- (2008) Liyan Qiao et al. Molecular Brain
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More